Relative risk of other common malignancies in individuals with nonmedullary thyroid cancer–affected first-degree relatives vs the general population of Taiwan
. | . | With affected relatives . | General population . | . | ||
---|---|---|---|---|---|---|
. | Sex . | No. . | Prevalence, ‰ . | No. . | Prevalence, ‰ . | Adjusted RRa (95% CI) . |
Breast cancer | Male | 2 | 0.05 | 499 | 0.04 | 2.05 (0.52-8.06) |
Female | 288 | 7.98 | 129 897 | 10.93 | 1.15 (1.02-1.28)b | |
All | 290 | 3.93 | 130 396 | 5.50 | 1.15 (1.03-1.29)b | |
Colorectal cancer | Male | 119 | 3.16 | 59 446 | 5.03 | 1.01 (0.84-1.20) |
Female | 131 | 3.63 | 48 859 | 4.11 | 1.37 (1.15-1.62)b | |
All | 250 | 3.39 | 108 305 | 4.57 | 1.17 (1.03-1.32)b | |
Lung cancer | Male | 69 | 1.83 | 22 184 | 1.88 | 1.59 (1.26-2.01)b |
Female | 66 | 1.83 | 21 351 | 1.80 | 1.55 (1.22-1.97)b | |
All | 135 | 1.82 | 43 535 | 1.84 | 1.56 (1.32-1.85)b | |
Liver cancer | Male | 75 | 1.99 | 33 726 | 2.86 | 1.09 (0.87-1.37) |
Female | 33 | 0.91 | 14 681 | 1.24 | 1.19 (0.85-1.67) | |
All | 108 | 1.46 | 48 407 | 2.04 | 1.13 (0.94-1.36) | |
Leukemia and lymphoma | Male | 62 | 1.65 | 18 515 | 1.57 | 1.31 (1.02-1.67)b |
Female | 45 | 1.25 | 15 778 | 1.33 | 1.17 (0.86-1.56) | |
All | 107 | 1.45 | 34 293 | 1.45 | 1.24 (1.03-1.50)b |
. | . | With affected relatives . | General population . | . | ||
---|---|---|---|---|---|---|
. | Sex . | No. . | Prevalence, ‰ . | No. . | Prevalence, ‰ . | Adjusted RRa (95% CI) . |
Breast cancer | Male | 2 | 0.05 | 499 | 0.04 | 2.05 (0.52-8.06) |
Female | 288 | 7.98 | 129 897 | 10.93 | 1.15 (1.02-1.28)b | |
All | 290 | 3.93 | 130 396 | 5.50 | 1.15 (1.03-1.29)b | |
Colorectal cancer | Male | 119 | 3.16 | 59 446 | 5.03 | 1.01 (0.84-1.20) |
Female | 131 | 3.63 | 48 859 | 4.11 | 1.37 (1.15-1.62)b | |
All | 250 | 3.39 | 108 305 | 4.57 | 1.17 (1.03-1.32)b | |
Lung cancer | Male | 69 | 1.83 | 22 184 | 1.88 | 1.59 (1.26-2.01)b |
Female | 66 | 1.83 | 21 351 | 1.80 | 1.55 (1.22-1.97)b | |
All | 135 | 1.82 | 43 535 | 1.84 | 1.56 (1.32-1.85)b | |
Liver cancer | Male | 75 | 1.99 | 33 726 | 2.86 | 1.09 (0.87-1.37) |
Female | 33 | 0.91 | 14 681 | 1.24 | 1.19 (0.85-1.67) | |
All | 108 | 1.46 | 48 407 | 2.04 | 1.13 (0.94-1.36) | |
Leukemia and lymphoma | Male | 62 | 1.65 | 18 515 | 1.57 | 1.31 (1.02-1.67)b |
Female | 45 | 1.25 | 15 778 | 1.33 | 1.17 (0.86-1.56) | |
All | 107 | 1.45 | 34 293 | 1.45 | 1.24 (1.03-1.50)b |
Abbreviation: RR, relative risk.
aAdjusted for age, sex, place of residence, quintiles of income level, occupation, and family size.
bP less than .05.
Relative risk of other common malignancies in individuals with nonmedullary thyroid cancer–affected first-degree relatives vs the general population of Taiwan
. | . | With affected relatives . | General population . | . | ||
---|---|---|---|---|---|---|
. | Sex . | No. . | Prevalence, ‰ . | No. . | Prevalence, ‰ . | Adjusted RRa (95% CI) . |
Breast cancer | Male | 2 | 0.05 | 499 | 0.04 | 2.05 (0.52-8.06) |
Female | 288 | 7.98 | 129 897 | 10.93 | 1.15 (1.02-1.28)b | |
All | 290 | 3.93 | 130 396 | 5.50 | 1.15 (1.03-1.29)b | |
Colorectal cancer | Male | 119 | 3.16 | 59 446 | 5.03 | 1.01 (0.84-1.20) |
Female | 131 | 3.63 | 48 859 | 4.11 | 1.37 (1.15-1.62)b | |
All | 250 | 3.39 | 108 305 | 4.57 | 1.17 (1.03-1.32)b | |
Lung cancer | Male | 69 | 1.83 | 22 184 | 1.88 | 1.59 (1.26-2.01)b |
Female | 66 | 1.83 | 21 351 | 1.80 | 1.55 (1.22-1.97)b | |
All | 135 | 1.82 | 43 535 | 1.84 | 1.56 (1.32-1.85)b | |
Liver cancer | Male | 75 | 1.99 | 33 726 | 2.86 | 1.09 (0.87-1.37) |
Female | 33 | 0.91 | 14 681 | 1.24 | 1.19 (0.85-1.67) | |
All | 108 | 1.46 | 48 407 | 2.04 | 1.13 (0.94-1.36) | |
Leukemia and lymphoma | Male | 62 | 1.65 | 18 515 | 1.57 | 1.31 (1.02-1.67)b |
Female | 45 | 1.25 | 15 778 | 1.33 | 1.17 (0.86-1.56) | |
All | 107 | 1.45 | 34 293 | 1.45 | 1.24 (1.03-1.50)b |
. | . | With affected relatives . | General population . | . | ||
---|---|---|---|---|---|---|
. | Sex . | No. . | Prevalence, ‰ . | No. . | Prevalence, ‰ . | Adjusted RRa (95% CI) . |
Breast cancer | Male | 2 | 0.05 | 499 | 0.04 | 2.05 (0.52-8.06) |
Female | 288 | 7.98 | 129 897 | 10.93 | 1.15 (1.02-1.28)b | |
All | 290 | 3.93 | 130 396 | 5.50 | 1.15 (1.03-1.29)b | |
Colorectal cancer | Male | 119 | 3.16 | 59 446 | 5.03 | 1.01 (0.84-1.20) |
Female | 131 | 3.63 | 48 859 | 4.11 | 1.37 (1.15-1.62)b | |
All | 250 | 3.39 | 108 305 | 4.57 | 1.17 (1.03-1.32)b | |
Lung cancer | Male | 69 | 1.83 | 22 184 | 1.88 | 1.59 (1.26-2.01)b |
Female | 66 | 1.83 | 21 351 | 1.80 | 1.55 (1.22-1.97)b | |
All | 135 | 1.82 | 43 535 | 1.84 | 1.56 (1.32-1.85)b | |
Liver cancer | Male | 75 | 1.99 | 33 726 | 2.86 | 1.09 (0.87-1.37) |
Female | 33 | 0.91 | 14 681 | 1.24 | 1.19 (0.85-1.67) | |
All | 108 | 1.46 | 48 407 | 2.04 | 1.13 (0.94-1.36) | |
Leukemia and lymphoma | Male | 62 | 1.65 | 18 515 | 1.57 | 1.31 (1.02-1.67)b |
Female | 45 | 1.25 | 15 778 | 1.33 | 1.17 (0.86-1.56) | |
All | 107 | 1.45 | 34 293 | 1.45 | 1.24 (1.03-1.50)b |
Abbreviation: RR, relative risk.
aAdjusted for age, sex, place of residence, quintiles of income level, occupation, and family size.
bP less than .05.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.